The Drug Science Podcast Por arte de portada

The Drug Science Podcast

De: Drug Science
Escúchala gratis

  • Resumen

  • Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.
    Drug Science
    Más Menos
Episodios
  • 104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy

    104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy
    May 22 2024

    In this episode, we meet with Dr. Suresh Muthukumaraswamy, an Associate Professor of Pharmacy in Auckland. Dr. Muthukumaraswamy discusses his early research, exploring the functional connectivity of substances like DMT and Ketamine. He proceeds to share insights into his breakthrough realisation regarding the disparity between the self-reported success of microdosing outside the lab setting and why it has failed to be replicated in controlled research settings. Finally, he shares his opinions on recent developments of drug policy in Australia and the prospects of New Zealand adopting a similar policy.

    Ketamine

    DMT

    LSD

    Fmri

    MEG

    EEG

    PET

    5-HT Receptor

    Microdosing

    Neuroplasticity

    Endocrine

    Menstural Cycle Hormones

    Australia Law on MDMA and Psilocybin

    Research

    Support the podcast

    ★ Support this podcast ★
    Más Menos
    45 m
  • 103. Neuroimaging with Prof Mitul Mehta

    103. Neuroimaging with Prof Mitul Mehta
    May 8 2024
    Professor Mitul Mehta explains how his studies in neuroscience and the role of dopamine in learning and memory led to his own career in neuroimaging. He offers an overview of what neuroimaging entails and how these scans can contribute to the advancement of research. Drawing from his latest research centred around Schizophrenia, Mitul delves into our understanding of drug interactions within the brain and how these can be used in drug development.DopamineDopaminergic systemExecutive functionEpisodic memoryBrain imagingLesion StudyPet scannerTemporal resolutionFmriMRIReceptorsneuronsBlood Brain BarrierKetamineCocainePsilocybinSchizophrenia
    Más Menos
    1 h y 2 m
  • 102. MDMA and the Octopus with Dr Gül Dölen

    102. MDMA and the Octopus with Dr Gül Dölen
    Apr 24 2024

    In this episode, Prof Neill and Dr Thurgur meet with Dr Gül Dölen, a neuroscientist known for studying social behaviour and psychedelic drugs. Together, they explore the role of critical periods in trauma and mental health; following the potential of Psychedelics in reopening critical periods which were previously thought to be closed, they debate whether a critical period closing is ever truly permanent.

    Critical period

    Sensitive period

    Lorenz 1935

    MDMA

    cocaine

    Oxytocin

    Ibogaine

    psilocybin

    Theory of mind

    Albert Hofmann

    Schizophrenia

    Become a Drug Science Community Member

    ★ Support this podcast ★
    Más Menos
    1 h y 7 m
Ciencias Sociales Ciencia
Más Menos

Lo que los oyentes dicen sobre The Drug Science Podcast

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles